Dietrich Stephan, general partner of Cyto Ventures, is a human geneticist and entrepreneur who works in personalized medicine.  Trained as part of the Human Genome Project through the National Institutes for Health (NIH), he spent part of his career in San Francisco helping build the national infrastructure through which to deliver genetic information to the medical industry.His insight on moving innovation into commercialization and licensing landed him an opportunity to work with the University of Pittsburgh.He launched CytoVentures to give biotech founders access to infrastructure, expertise and a network of equity investment.  Through its own fund and network of investors, Cyto has helped raise over $400 million for about a dozen startups.Listen in as he discussed the future of life sciences and biotech and his experience as both an operator and investor.Cyto Ventures is based in Pittsburgh, PA.